Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization.

@article{Tuppin2010EvidencebasedPA,
  title={Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization.},
  author={Philippe Tuppin and Anke Neumann and Nicolas Danchin and Christine de Peretti and Alain Weill and Philippe Ricordeau and Hubert Allemand},
  journal={Archives of cardiovascular diseases},
  year={2010},
  volume={103 6-7},
  pages={363-75}
}
BACKGROUND International guidelines recommend long-term use of evidence-based treatment (EBT) combining beta-blockers, aspirin/clopidogrel, statins and either angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACEIs/ARBs) after a myocardial infarction (MI), to reduce cardiac morbidity and mortality. AIMS To evaluate medication adherence after hospital admission for MI and the relationship with mortality and readmission for acute coronary syndrome. METHODS… CONTINUE READING
40 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 40 extracted citations

Similar Papers

Loading similar papers…